Registration

Opening

Translocator Protein as a Promising Target for Novel Anxiolytics

New Selective Androgen Receptor Modulators (SARM) for the Treatment of Cachexia

Coffee Break

Therapeutic Targeting of TLR Signalling

Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Discovery of an Orally Active TDO Inhibitor

Sandwich Lunch

Drug-to-Genome-to-Drug: Discovery and Optimisation of an Antimalarial Compound

Can Medicinal Chemistry Solve Target Related Issues?

MASPIT, a Strategy for Small Molecule-Protein Interaction Mapping in Intact Human Cells

Coffee Break and Poster Session

Targeting GSK-3 with ATP Non-Competitive Inhibitors: From the Bench to the Clinical Trials

New Targets for the Treatment of HIV

Closing Remarks